Litigation Details for Pfizer Inc. v. Breckenridge Pharmaceutical Inc. (D. Del. 2017)
✉ Email this page to a colleague
Pfizer Inc. v. Breckenridge Pharmaceutical Inc. (D. Del. 2017)
| Docket | ⤷ Try a Trial | Date Filed | 2017-10-30 |
| Court | District Court, D. Delaware | Date Terminated | 2018-06-06 |
| Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | None | Referred To | |
| Parties | PENSA PHARMA S.A. | ||
| Patents | 6,956,041; 6,965,027; 7,091,208; 7,265,221; 7,301,023; RE41,783 | ||
| Attorneys | John C. Phillips , Jr. | ||
| Firms | Phillips, McLaughlin & Hall, P.A. | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Pfizer Inc. v. Breckenridge Pharmaceutical Inc.
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Biologic Drugs cited in Pfizer Inc. v. Breckenridge Pharmaceutical Inc.
The biologic drug covered by the patents cited in this case is ⤷ Try a Trial .
Details for Pfizer Inc. v. Breckenridge Pharmaceutical Inc. (D. Del. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2017-10-30 | 1 | United States Patent Nos. 6,956,041 (the “’041 patent”); 7,091,208 (the “’208 patent); 7,265,221 (the…the “’221 patent”); and RE41,783 (the “’783 patent”). 2. This action arises out of Breckenridge…’208, and ’221 patents as December 8, 2020 and the expiration date for the ’783 patent as December 8,…also lists two additional patents for Xeljanz® that are not at issue: U.S. Patent Nos. 6,965,027 (expiring…1, 2017, addressed U.S. Patent Nos. 6,965,027 and 7,301,023. The ’041 Patent 30. On October | External link to document | |
| 2017-10-30 | 3 | Notice: 9/22/2017. Date of Expiration of Patent: 6,956,041; 7,091,208; and 7,265,221 - December 8, 2020… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) … 2017 6 June 2018 1:17-cv-01532 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
| 2017-10-30 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,956,041; 7,091,208; 7,265,221… 2017 6 June 2018 1:17-cv-01532 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
